24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Sleep Disorders
Basic InformationLatest News
How to Sleep Better During the PandemicAHA News: Exercise May Reduce Sleep Apnea and Improve Brain HealthSleep Apnea Patients Struggle as Common CPAP Machine Is RecalledRecall of Philips Breathing Machines Affects Millions of Americans'Date Rape' Drug Gets FDA Approval to Treat Rare Sleep DisorderSleep Apnea Doubles Odds for Sudden DeathAHA News: Severe Sleep Apnea Could Damage Key Blood VesselsWant to Avoid Sleep Apnea? Get Off the SofaSleepless Nights Can Quickly Mess Up Your EmotionsSleep Apnea in Childhood a Bad Sign for Teenage Heart HealthMore Than a Snore? Recognize the Signs of Sleep ApneaWhy Music at Bedtime Might Not Be a Great IdeaPoor Sleep After Head Injury Could Point to Dementia RiskNew Links Between Poor Sleep, Diabetes and DeathAHA News: Kids With Sleep Apnea Into Teen Years Could Develop High Blood PressureSleep Apnea Raises Odds for Severe COVID-19Do Prescription Sleep Medicines Even Work?Sleep Disorders Cost U.S. Health Care System Nearly $95 Billion Per YearLullaby Effect: Music Can Speed Your Way to Sleep, Study Finds'Disrupted' Sleep Could Be Seriously Affecting Your HealthSleepwalking Tied to Higher Odds for Parkinson's in MenSleep Issues Are Soaring in U.S. Military: StudyGrumpy? Depressed? Try a More Regular Sleep ScheduleCPAP Mask for Sleep Apnea May Boost Daytime Activity LevelsFDA Approves 'Tongue Strengthening' Device for Certain Sleep Apnea PatientsAHA News: Sleep Disorders Plague Stroke Survivors – and Put Them at RiskHow to Sleep Better in 2021Once Begun, Insomnia Is Tough to Shake: StudyDoes Taking Screens Away Help Sleep-Deprived Teens?Associated Professional Sleep Societies, June 5-9, 2010
Questions and AnswersLinks
Related Topics

Medical Disorders
Mental Disorders

'Date Rape' Drug Gets FDA Approval to Treat Rare Sleep Disorder

HealthDay News
by Robert Preidt and Robin Foster
Updated: Aug 13th 2021

new article illustration

FRIDAY, Aug. 13, 2021 (HealthDay News) -- The drug Xywav has been approved for expanded use in adults with a rare sleep disorder called idiopathic hypersomnia, the U.S. Food and Drug Administration said Thursday.

The drug has a checkered history: In the 1960s, it was given to women during childbirth to dampen their consciousness, The New York Times reported, while an illicit version made headlines as a "date rape" drug in the 1990s.

It's the first drug to be approved by the FDA for idiopathic hypersomnia, which causes excessive daytime sleepiness even after a good night's sleep.

The oral drug was already approved for the treatment of excessive daytime sleepiness and sudden loss of muscle tone in patients aged 7 and older with narcolepsy.

"Idiopathic hypersomnia is a lifelong condition, and the approval of Xywav will be instrumental in providing treatment for symptoms such as excessive sleepiness and difficulty waking, and in effectively managing this debilitating disorder," Dr. Eric Bastings, deputy director of the Office of Neuroscience in the FDA's Center for Drug Evaluation and Research, said in an agency news release.

The approval is based on a clinical trial that included 154 adult patients, aged 19 to 75. Those who were switched from Xywav to a placebo experienced worsening sleepiness and symptoms of idiopathic hypersomnia compared to those who continued taking the drug, according to the FDA.

The most common side effects of the drug were nausea (21.4%), headache (16.2%), dizziness (11.7%), anxiety (10.4%) and vomiting (10.4%).

Xywav has a boxed warning for central nervous system depression and abuse and misuse, which can cause serious side effects such as seizures, trouble breathing, changes in alertness, coma and death, the FDA said.

Due to the potential risks of the drug, it's subject to strict prescribing and dispensing controls, and is not available in retail pharmacies.

Xywav can be prescribed only by a certified prescriber and dispensed only to an enrolled patient by a certified pharmacy that ships directly to patients, the FDA said.

Some experts said the evidence to support the new approval is weak. And they worry about the dangers of the medication, which acts so swiftly that its label advises users to take it while in bed, the Times reported.

The drug "has serious safety concerns, both in terms of its abuse liability and its addictive potential," Dr. Lewis Nelson, director of medical toxicology at Rutgers New Jersey Medical School, told the Times.

More information

Visit the National Heart, Lung, and Blood Institute for more on insomnia.

SOURCE: U.S. Food and Drug Administration